Plus Therapeutics, Inc. | CYTX - Operating Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Plus Therapeutics, Inc.

Plus Therapeutics, Inc. reported $-4720000 in Operating Profit for its fiscal quarter ending in March of 2023.


Operating Profit Change
Baxter International BAX:US USD 186M 5M
Dr.Reddys Laboratories DRRD:IN INR 12.38B 3.77B
Haemonetics HAE:US USD 35.25M 8.02M
Infinity Pharmaceuticals INFI:US USD -11507000 1.97M
Merrimack Pharmaceuticals MACK:US USD -447000 160K
Mirati Therapeutics MRTX:US USD -193823000 17.9M
Northwest Biotherapeutics NWBO:US USD -14372000 6.34M
Plus Therapeutics, Inc. CYTX:US USD -4720000 852K
Starpharma Holdings Ltd SPL:AU AUD -8277000 572K
Sun Pharmaceuticals SUNP:IN INR 19.86B 3.61B
Teva Pharmaceutical Industries Ltd TEVA:IT USD 2M 857M